FDA is testing all valsartan heart drugs for a cancer link in probe - STAT

FDA is testing all valsartan heart drugs for a cancer link in probe - STAT

Another company recalls blood pressure drug due to contamination concerns

Another company is recalling a drug used to treat high blood pressure and heart failure over concerns it could be contaminated with a cancer-causing ingredient. A handful of companies have already recalled valsartan tablets after impurities known as NDMA and NDEA showed up in some of the drugs. Now, Aurobindo Pharma has recalled 80 lots of drugs that contained valsartan after finding trace amounts of NDEA. The FDA says patients taking any of the recalled medicines should reach out to a doctor or pharmacist to find a substitute, but should keep taking the drugs until they find a replacement. Not all drugs containing valsartan have been pulled from the market. Get the latest on the recall here.